{
    "clinical_study": {
        "@rank": "107717", 
        "acronym": "SAMIRA", 
        "arm_group": {
            "arm_group_label": "Population", 
            "arm_group_type": "Experimental", 
            "description": "Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5"
        }, 
        "brief_summary": {
            "textblock": "Use of brain natriuretic peptide to evaluate the cardiac function in the course of\n      meningococcal septic shock or severe sepsis."
        }, 
        "brief_title": "Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Meningococcal Infections", 
            "Septic Shock", 
            "Severe Sepsis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Meningococcal Infections", 
                "Sepsis", 
                "Toxemia", 
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: determining sensibility and specificity of BNP blood level to detect myocardial\n      dysfunction in septic shock or severe sepsis due to Neisseria meningitidis in children.\n\n      METHODS: Prospective multicentric clinical trial including 7 French pediatric intensive care\n      units. Serial cardiac ultra sounds and blood sampling will be done for patients hospitalized\n      for purpura fulminans beginning at the time of admission in pediatric intensive care. Any\n      child from 6 months to 18 years without preexisting cardiac disease and presenting with\n      purpura fulminans will be enrolled after obtaining consent of both parents. From adult's\n      studies on septic shock and BNP, a total number of 30 patients was calculated to be\n      necessary to prove the interest of BNP in this indication."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children\n\n          -  6 months to 18 years aged\n\n          -  without previous cardiac pathology\n\n          -  hospitalized in the participating pediatric intensive care units for serious sepsis\n             with extensive purpura\n\n        Exclusion Criteria:\n\n          -  Heart malformative disorder with right-left shunt\n\n          -  Pre-existent known cardiac insufficiency whatever is the origin\n\n          -  Concomitant participation in another trial\n\n          -  Patient in period of exclusion from another trial\n\n          -  Not membership in a national insurance scheme"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02041663", 
            "org_study_id": "AOR 10106"
        }, 
        "intervention": {
            "arm_group_label": "Population", 
            "description": "Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5", 
            "intervention_name": "BNP", 
            "intervention_type": "Biological"
        }, 
        "intervention_browse": {
            "mesh_term": "Natriuretic Peptide, Brain"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "brain natriuretic peptide", 
            "cardiac function", 
            "meningococcal infections", 
            "septic shock", 
            "severe sepsis"
        ], 
        "lastchanged_date": "January 20, 2014", 
        "location": {
            "contact": {
                "last_name": "Jean Bergougnoux, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "AP-HP, Necker hospital"
            }, 
            "investigator": {
                "last_name": "Jean Bergougnoux, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis", 
        "overall_contact": {
            "email": "jean.bergounioux@nck.aphp.fr", 
            "last_name": "Jean Bergounioux, MD", 
            "phone": "+33 (0)1 44 49 42 18"
        }, 
        "overall_official": {
            "affiliation": "AP-HP", 
            "last_name": "Jean Bergougnoux, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Repeated brain natriuretic peptide (BNP) blood level", 
            "safety_issue": "No", 
            "time_frame": "Up to day 5"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02041663"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Repeated cardiac  echography", 
                "safety_issue": "No", 
                "time_frame": "Up to day 5"
            }, 
            {
                "measure": "PRISM II gravity score", 
                "safety_issue": "No", 
                "time_frame": "Up to day 5"
            }, 
            {
                "measure": "Organ failure PELOD score", 
                "safety_issue": "No", 
                "time_frame": "Up to day 5"
            }, 
            {
                "measure": "Troponin rate", 
                "safety_issue": "No", 
                "time_frame": "Up to day 5"
            }, 
            {
                "measure": "mortality and morbidity (aftereffects)", 
                "safety_issue": "No", 
                "time_frame": "Day 28 and hospital discharge"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}